Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy

Despite combination chemotherapy demonstrating a positive effect on survival, the clinical outcomes of pancreatic adenocarcinoma (PDAC) remain poor. Radiotherapy was previously a component of the curative treatment of PDAC. Advances in imaging and computer sciences have enabled the prescription of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Jan, I-Shiow, Ch’ang, Hui Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439654/
https://www.ncbi.nlm.nih.gov/pubmed/37596627
http://dx.doi.org/10.1186/s13014-023-02328-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439654/
https://www.ncbi.nlm.nih.gov/pubmed/37596627
http://dx.doi.org/10.1186/s13014-023-02328-y

Ejemplares similares